(News Bulletin 247) – The company announced yesterday that it has decided to appeal the judgment of the Commercial Court in the case that has pitted it against Bpifrance since 2014.
Invest Securities confirms its neutral advice on the value with a price target of 3.3 E.
‘ Exactly 1 month ago, the company announced that the Commercial Court of Montpellier had rendered a verdict in favor of Bpifrance condemning Medesis
to pay €1.4m to Bpifrance’ reminds Invest Securities.
“If the company had then announced its intention to negotiate with the management of Bpifrance to identify a suitable repayment plan, it seems that the intentions probably changed following the discussions initiated. From now on, Medesis
intends to appeal to obtain a reversal of the Court’s decision and avoid the payment of 1.4mE which represents a significant sum on the scale of Medesis ‘indicates the analysis office.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
